Global Contract Pharmaceutical Manufacturing Sales Report Thumbnail

Global Contract Pharmaceutical Manufacturing Sales Market by Type (API, FDF), By Application (Specialty/Midsize, Generics, Big Pharma, Other) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast To 2028

  • Report ID: PH-61858
  • Author: Up Market Research
  • Rating: 4.6
  • Total Reviews: 58
  • No. Of Pages: 230
  • Format:
  • Pub. Date: 2021-04-04
  • Share:

Up Market Research published a new report titled “Contract Pharmaceutical Manufacturing Sales Market research report which is segmented by Types (API, FDF), By Applications (Specialty/Midsize, Generics, Big Pharma, Other), By Players/Companies Catalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim, Fareva Holding, AbbVie, Nipro Corp, Vetter, Sopharma, DPT Laboratories, Recipharm, NextPharma, Dishman, Aesica”. As per the study the market is expected to grow at a CAGR of XX% in the forecast period.


Report Scope

Report AttributesReport Details
Report TitleContract Pharmaceutical Manufacturing Sales Market Research Report
By TypeAPI, FDF
By ApplicationSpecialty/Midsize, Generics, Big Pharma, Other
By CompaniesCatalent, DPx, Lonza, Piramal Healthcare, Aenova, Jubilant, Famar, Boehringer Ingelheim, Fareva Holding, AbbVie, Nipro Corp, Vetter, Sopharma, DPT Laboratories, Recipharm, NextPharma, Dishman, Aesica
Regions CoveredNorth America, Europe, APAC, Latin America, MEA
Base Year2020
Historical Year2018 to 2019 (Data from 2010 can be provided as per availability)
Forecast Year2028
Number of Pages230
Number of Tables & Figures161
Customization AvailableYes, the report can be customized as per your need.

The report covers comprehensive data on emerging trends, market drivers, growth opportunities, and restraints that can change the market dynamics of the industry. It provides an in-depth analysis of the market segments which include products, applications, and competitor analysis.


Global Contract Pharmaceutical Manufacturing Sales Industry Outlook

Global Contract Pharmaceutical Manufacturing Sales Market Report Segments:

The market is segmented by Type API, FDF and By Application Specialty/Midsize, Generics, Big Pharma, Other.


Some of the companies that are profiled in this report are:

  1. Catalent
  2. DPx
  3. Lonza
  4. Piramal Healthcare
  5. Aenova
  6. Jubilant
  7. Famar
  8. Boehringer Ingelheim
  9. Fareva Holding
  10. AbbVie
  11. Nipro Corp
  12. Vetter
  13. Sopharma
  14. DPT Laboratories
  15. Recipharm
  16. NextPharma
  17. Dishman
  18. Aesica

Contract Pharmaceutical Manufacturing Sales Market research report delivers a close watch on leading competitors with strategic analysis, micro and macro market trend and scenarios, pricing analysis and a holistic overview of the market situations in the forecast period. It is a professional and a detailed report focusing on primary and secondary drivers, market share, leading segments and geographical analysis. Further, key players, major collaborations, merger & acquisitions along with trending innovation and business policies are reviewed in the report.


Key Benefits for Industry Participants & Stakeholders:

  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Contract Pharmaceutical Manufacturing Sales Market

Overview of the regional outlook of the Contract Pharmaceutical Manufacturing Sales Market:

Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa (MEA). North America region is further bifurcated into countries such as U.S., and Canada. The Europe region is further categorized into U.K., France, Germany, Italy, Spain, Russia, and Rest of Europe. Asia Pacific is further segmented into China, Japan, South Korea, India, Australia, South East Asia, and Rest of Asia Pacific. Latin America region is further segmented into Brazil, Mexico, and Rest of Latin America, and the MEA region is further divided into GCC, Turkey, South Africa, and Rest of MEA.


Contract Pharmaceutical Manufacturing Sales Market Overview

Highlights of The Contract Pharmaceutical Manufacturing Sales Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of Contract Pharmaceutical Manufacturing Sales Market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2028.
  5. Developments and trends in the market.
  6. By Type:

                1. API

                2. FDF

       7. By Application:

                1. Specialty/Midsize

                2. Generics

                3. Big Pharma

                4. Other

  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Contract Pharmaceutical Manufacturing Sales Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2028.


How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Contract Pharmaceutical Manufacturing Sales Market Statistics

Reasons to Purchase the Contract Pharmaceutical Manufacturing Sales Market Report:

  • The report includes a plethora of information such as market dynamics scenario and opportunities during the forecast period
  • Segments and sub-segments include quantitative, qualitative, value (USD Million,) and volume (Units Million) data.
  • Regional, sub-regional, and country level data includes the demand and supply forces along with their influence on the market.
  • The competitive landscape comprises share of key players, new developments, and strategies in the last three years.
  • Comprehensive companies offering products, relevant financial information, recent developments, SWOT analysis, and strategies by these players.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Contract Pharmaceutical Manufacturing Sales Market Overview
   4.1 Introduction 
      4.1.1 Market Taxonomy 
      4.1.2 Market Definition 
      4.1.3 Macro-Economic Factors Impacting the Market Growth 
   4.2 Contract Pharmaceutical Manufacturing Sales Market Dynamics 
      4.2.1 Market Drivers 
      4.2.2 Market Restraints 
      4.2.3 Market Opportunity 
   4.3 Contract Pharmaceutical Manufacturing Sales Market - Supply Chain Analysis 
      4.3.1 List of Key Suppliers 
      4.3.2 List of Key Distributors 
      4.3.3 List of Key Consumers 
   4.4 Key Forces Shaping the Contract Pharmaceutical Manufacturing Sales Market 
      4.4.1 Bargaining Power of Suppliers 
      4.4.2 Bargaining Power of Buyers 
      4.4.3 Threat of Substitution 
      4.4.4 Threat of New Entrants 
      4.4.5 Competitive Rivalry 
   4.5 Global Contract Pharmaceutical Manufacturing Sales Market Size & Forecast, 2018-2028 
      4.5.1 Contract Pharmaceutical Manufacturing Sales Market Size and Y-o-Y Growth 
      4.5.2 Contract Pharmaceutical Manufacturing Sales Market Absolute $ Opportunity 


Chapter 5 Global Contract Pharmaceutical Manufacturing Sales Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Type
      5.2.1 API
      5.2.2 FDF
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Contract Pharmaceutical Manufacturing Sales Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Applications
      6.2.1 Specialty/Midsize
      6.2.2 Generics
      6.2.3 Big Pharma
      6.2.4 Other
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Contract Pharmaceutical Manufacturing Sales Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Contract Pharmaceutical Manufacturing Sales Analysis and Forecast
   9.1 Introduction
   9.2 North America Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Type
      9.6.1 API
      9.6.2 FDF
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Applications
      9.10.1 Specialty/Midsize
      9.10.2 Generics
      9.10.3 Big Pharma
      9.10.4 Other
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Contract Pharmaceutical Manufacturing Sales Analysis and Forecast
   10.1 Introduction
   10.2 Europe Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Type
      10.6.1 API
      10.6.2 FDF
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Applications
      10.10.1 Specialty/Midsize
      10.10.2 Generics
      10.10.3 Big Pharma
      10.10.4 Other
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Contract Pharmaceutical Manufacturing Sales Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Type
      11.6.1 API
      11.6.2 FDF
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Applications
      11.10.1 Specialty/Midsize
      11.10.2 Generics
      11.10.3 Big Pharma
      11.10.4 Other
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Contract Pharmaceutical Manufacturing Sales Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Type
      12.6.1 API
      12.6.2 FDF
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Applications
      12.10.1 Specialty/Midsize
      12.10.2 Generics
      12.10.3 Big Pharma
      12.10.4 Other
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Contract Pharmaceutical Manufacturing Sales Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Type
      13.6.1 API
      13.6.2 FDF
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Contract Pharmaceutical Manufacturing Sales Market Size Forecast by Applications
      13.10.1 Specialty/Midsize
      13.10.2 Generics
      13.10.3 Big Pharma
      13.10.4 Other
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Contract Pharmaceutical Manufacturing Sales Market: Competitive Dashboard
   14.2 Global Contract Pharmaceutical Manufacturing Sales Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Catalent
      14.3.2 DPx
      14.3.3 Lonza
      14.3.4 Piramal Healthcare
      14.3.5 Aenova
      14.3.6 Jubilant
      14.3.7 Famar
      14.3.8 Boehringer Ingelheim
      14.3.9 Fareva Holding
      14.3.10 AbbVie
      14.3.11 Nipro Corp
      14.3.12 Vetter
      14.3.13 Sopharma
      14.3.14 DPT Laboratories
      14.3.15 Recipharm
      14.3.16 NextPharma
      14.3.17 Dishman
      14.3.18 Aesica
Segments Covered in the Report
The global Contract Pharmaceutical Manufacturing Sales market has been segmented based on

By Types
  • API
  • FDF
By Applications
  • Specialty/Midsize
  • Generics
  • Big Pharma
  • Other
Regions
  • Asia Pacific
  • North America
  • Latin America
  • Europe
  • Middle East & Africa
Key Players
  • Catalent
  • DPx
  • Lonza
  • Piramal Healthcare
  • Aenova
  • Jubilant
  • Famar
  • Boehringer Ingelheim
  • Fareva Holding
  • AbbVie
  • Nipro Corp
  • Vetter
  • Sopharma
  • DPT Laboratories
  • Recipharm
  • NextPharma
  • Dishman
  • Aesica

Buy Report